Pathway | Up | Down |
---|---|---|
Chemokine signaling pathway | GNB4, RAC1, IL8, GNG5, HCK, RAC2, FOXO3, RAP1B, SOS2, ADRBK1, NCF1, GNAI2, CCL27, VAV3, RHOA, ADCY4, ARRB2, NFKBIB | GNB1, PLCB3, CCL5, CXCL9, RAP1A, CXCR3, GNG8, GNG2, CCL21, AKT3, CRKL, MAPK1, PRKACG, PRKACA, CHUK, CCL11, BRAF, MAP2K1, RASGRP2 |
Cell adhesion molecules (CAMs) | HLA-DQB1, ITGB7, HLA-A, HLA-B, HLA-B, HLA-DMA, NRXN2, HLA-DPA1, HLA-DRB1, HLA-DRB1, ALCAM, CLDN18, CLDN14 | MPZL1, HLA-E, HLA-F, CADM3, CADM1, CD34, CD8A, CD99, CDH3, CLDN4, CLDN6, NCAM1, GLG1, NLGN2, ITGB2, ITGB8, ITGA9, CNTNAP1, SIGLEC1 |
Cytokine-cytokine receptor interaction | IL1, RAP, IL8, TGFB1, IL1B, CSF1R, IL23A, BMP8A, CCL27, BMP4, BMPR2 | GHR, CCL5, CD70, CXCL9, KIT, CD27, CXCR3, TNFα, IL2RG, CNTFR, BMPR1A, IL23R, CCL21, TGFB3, FLT4, BMP5, IFNGR2, LTA, IL9, CCL11, TNFSF10, ACVR2A |
Leukocyte trans-endothelial migration | RAC1, CYBA, CYBB, RAC2, RAP1B, ACTG1, NCF1, GNAI2, EZR, ACTN4, VAV3, RHOA, PTPN11, CLDN18, CLDN14, ACTB | RAP1A, CD99, RHOH, THY1, MAPK11, CTNNB1, CLDN4, CLDN6, ITGB2, MLLT4, PLCG1 |
Natural killer cell mediated cytotoxicity | RAC1, ARAF, HLA-A, HLA-B, RAC2, SOS2, VAV3, LAT, FCER1G, PTPN11, MAP2K2, PTPN6 | TYROBP, HLA-E, HLA-F, TNF, IFNGR2, MAPK1, PPP3CB, GZMB, ITGB2, TNFSF10, BRAF, MAP2K1, PLCG1 |
T cell receptor signaling pathway | SOS2, GRAP2, VAV3, LAT, RHOA, NFKBIB, MAP2K2, PTPN6, PAK2 | CD8A, FOS, TNF, NCK1, AKT3, MAPK11, MAPK1, PPP3CB, CHUK, MAP2K1, PLCG1 |
B cell receptor signaling pathway | RAC1, RAC2, SOS2, CD81, VAV3, LILRB3, NFKBIB, MAP2K2, PTPN6, CR2 | FOS, AKT3, MAPK1, PPP3CB, CHUK, MAP2K1 |
Antigen processing and presentation | HLA-DQB1, HLA-A, HLA-B, HLA-B, CD74, HLA-DMA, HLA-DPA1, HLA-DRB1, HLA-DRB1, HSP90AB1, CTSB, CTSS, HSP90AA1 | HLA-E, HLA-F, CD8A, TNF, TAPBP, HSPA5, PSME2 |
Complement and coagulation cascades | C4A, C3, C1S, SERPING1, CR2 | CD55, MASP2, KNG1, SERPINC1, F8, C9, C6, C3AR1, C5AR1 |